ATRA
Atara Biotherapeutics Inc
9.50$
+12.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 122.3% | 74.3% | 7.3% | 16.2% | 18.9% | 20.7% | 20.8% | 3.2% | 3.3% | 6.5% | 24.0% | 30.3% | 8.6% | |
| -22.3% | 25.7% | 92.7% | 83.8% | 81.1% | 79.3% | 79.2% | 96.8% | 96.7% | 93.5% | 76.0% | 69.7% | 91.4% | |
| 2,660.8% | 1,034.4% | 166.3% | 116.4% | 109.3% | 87.7% | 28.0% | 41.6% | 84.7% | 14.0% | 31.8% | 213.5% | 75.2% | |
| 572.8% | 269.4% | 40.6% | 31.1% | 25.9% | 28.8% | 11.7% | 33.8% | 115.5% | 268.2% | 697.1% | 605.4% | 253.1% | |
| 3,233.6% | 1,278.7% | 207.0% | 147.5% | 135.2% | 116.5% | 39.6% | 78.7% | 200.2% | 254.2% | 728.9% | 818.9% | 321.1% | |
| -3,255.9% | -1,253.0% | -114.2% | -63.7% | -54.1% | -37.3% | 39.5% | 18.2% | -103.5% | -160.7% | -652.9% | -749.2% | -229.7% | |
| 65.2% | 27.7% | 4.2% | 4.4% | 2.9% | 3.1% | 1.0% | 5.5% | 26.3% | 56.1% | 160.9% | 30.3% | 45.6% | |
| -3,265.5% | -1,421.4% | -116.0% | -66.5% | -54.6% | -38.8% | 38.7% | 13.6% | -123.8% | -213.5% | -803.3% | -767.1% | -269.0% | |
| -0.9% | 0.3% | 0.1% | 598.6% | 0.0% | -0.1% | – | 0.0% | 0.8% | – | – | 0.2% | – | |
| -3,264.6% | -1,421.7% | -116.1% | -66.5% | -54.5% | -38.8% | 38.7% | 13.6% | -124.6% | -213.5% | -803.3% | -767.3% | -269.4% | |
| -3,143.7% | -1,365.4% | -106.7% | -57.5% | -48.6% | -32.3% | 41.6% | 20.5% | -96.4% | -154.4% | -636.8% | -725.4% | -220.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.